Investment Counsel CO Of Nevada Tyra Biosciences, Inc. Transaction History
Investment Counsel CO Of Nevada
- $39.4 Billion
- Q4 2024
A detailed history of Investment Counsel CO Of Nevada transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Investment Counsel CO Of Nevada holds 85,020 shares of TYRA stock, worth $1.12 Million. This represents 3.0% of its overall portfolio holdings.
Number of Shares
85,020Holding current value
$1.12 Million% of portfolio
3.0%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
112Shares Held
49.9MCall Options Held
36.6KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.6MShares$140 Million2.39% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$55.1 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$53.8 Million89.47% of portfolio
-
Nextech Invest Ag4.06MShares$53.5 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$52 Million2.05% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $554M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...